CHLORAPREP ONE-STEP SEPP
LOE Approachingchlorhexidine gluconate and isopropyl alcohol
NDATOPICALSWAB
Approved
Oct 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CHLORAPREP ONE-STEP SEPP (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2002.
Drug data last refreshed 19h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLORAPREP ONE-STEP SEPP is a topical antiseptic swab combining chlorhexidine gluconate and isopropyl alcohol for rapid skin antisepsis prior to medical procedures. It is applied to skin to eliminate bacterial contamination and reduce infection risk at injection or incision sites. The dual-agent formulation provides broad-spectrum antimicrobial activity with rapid onset.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30); team focus likely shifting toward cost containment and market consolidation rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
Working on CHLORAPREP ONE-STEP SEPP offers limited growth trajectory but provides solid foundational experience in hospital-based commercial execution, formulary navigation, and mature product defense. This is a consolidation/optimization role rather than a growth opportunity; career value lies in gaining procedural-market expertise and contract management skills as the product transitions to post-LOE.
Worked on CHLORAPREP ONE-STEP SEPP at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.